Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AACR 2022
MedTech
Takeda, Presage microdose cancers to see how immune cells fight
Takeda is examining two therapies that could help break down the barriers protecting solid tumors from the body's immune system.
Conor Hale
Apr 13, 2022 4:34pm
AACR: AbbVie's navitoclax has yet to reach overall survival mark
Apr 12, 2022 11:24am
AACR: Novartis joins the KRAS bandwagon with early data
Apr 11, 2022 3:30pm
AACR: Exuma aims to be first to the clinic with subQ CAR therapy
Apr 11, 2022 11:18am
AACR: BioNTech's early cancer vaccine backs up new tumor target
Apr 11, 2022 11:14am
AACR: Blueprint wants to make resistance to Tagrisso futile
Apr 8, 2022 1:00pm
